| abstract |
The present invention describes triazolopyridinone derivatives as inhibitors of stearoyl-CoA unsaturated enzymes having the structure of formula (I). The compounds are useful in the treatment and / or prophylaxis of human diseases mediated by stearoyl-CoA unsaturated enzyme (SCD) enzymes, in particular diseases associated with abnormal lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome and the like. |